SK

Santosh Kumar Shrivastava

Active Director Additional Director DIN 08312183
DIN 08312183 First appointment Feb 2019 Primary industry Electrnoics
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Santosh Kumar Shrivastava

Data last updated:

Santosh Kumar Shrivastava is an Additional Director at Dzenlife Pharmaceuticals Private Limited (since 2019). The company operates in Electrnoics.

DIN 08312183
Primary Designation Additional Director
Industry Electrnoics
First Appointment 14 Feb 2019
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director14 Feb 20192018Active

Board colleagues of Santosh Kumar Shrivastava

Directorship timeline

Open interactive timeline →
Dzenlife Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Santosh Kumar Shrivastava

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Santosh Kumar Shrivastava

Santosh Kumar Shrivastava currently holds 1 directorship: Dzenlife Pharmaceuticals Private Limited (Additional Director, since 14 Feb 2019).

Santosh Kumar Shrivastava was first appointed on 14 Feb 2019 as Additional Director at Dzenlife Pharmaceuticals Private Limited.

The current boards of Santosh Kumar Shrivastava's companies include Monika Srivastava (Dzenlife Pharmaceuticals Private Limited), Sweta Priyadarshi (Dzenlife Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available